Lauren Hudak1, Ameen Jaraisy1, Saeda Haj1, Khitam Muhsen1. 1. Department of Epidemiology and Preventive Medicine, School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Abstract
BACKGROUND: We conducted an updated systematic review and meta-analysis to examine the prevalence of depleted iron stores among persons infected with Helicobacter pylori compared to uninfected ones. We also assessed the impact of anti-H. pylori eradication therapy plus iron therapy on ferritin and hemoglobin levels compared to iron therapy alone. METHODS: A literature search was conducted using the databases Medline, the Cochrane Library, Cochrane Central Register of Controlled Trials, EMBASE, and the Science Citation Index Expanded. Observational studies with methodological quality score of 13 (median score) and above, on a scale of 0-16, and all randomized controlled trials (RCTs) were eligible for the meta-analyses. Pooled point estimates and 95% confidence intervals (CI) were obtained using the random effects model. RESULTS: Compared to uninfected persons, H. pylori-infected individuals showed increased likelihood of iron deficiency anemia (14 observational studies); pooled OR 1.72 (95% CI 1.23-2.42); iron deficiency (pooled OR 1.33; 95% CI 1.15-1.54; 30 studies); and anemia (pooled OR 1.15; 95% CI 1.00-1.32; 23 studies). Meta-analyses of seven RCTs showed increased ferritin, standardized mean difference (SMD) 0.53 (95% 0.21-0.85), but not hemoglobin, SMD 0.36 (95% -0.07 to 0.78), Pv=.1, following anti-H. pylori eradication therapy plus iron therapy as compared with iron therapy alone. Significant heterogeneity was found among studies, as well as evidence of publication bias. CONCLUSIONS: Current evidence indicates increased likelihood of depleted iron stores in relation to H. pylori infection. H. pylori eradication therapy, added to iron therapy, might be beneficial in increasing ferritin and hemoglobin levels.
BACKGROUND: We conducted an updated systematic review and meta-analysis to examine the prevalence of depleted iron stores among persons infected with Helicobacter pylori compared to uninfected ones. We also assessed the impact of anti-H. pylori eradication therapy plus iron therapy on ferritin and hemoglobin levels compared to iron therapy alone. METHODS: A literature search was conducted using the databases Medline, the Cochrane Library, Cochrane Central Register of Controlled Trials, EMBASE, and the Science Citation Index Expanded. Observational studies with methodological quality score of 13 (median score) and above, on a scale of 0-16, and all randomized controlled trials (RCTs) were eligible for the meta-analyses. Pooled point estimates and 95% confidence intervals (CI) were obtained using the random effects model. RESULTS: Compared to uninfected persons, H. pylori-infected individuals showed increased likelihood of iron deficiency anemia (14 observational studies); pooled OR 1.72 (95% CI 1.23-2.42); iron deficiency (pooled OR 1.33; 95% CI 1.15-1.54; 30 studies); and anemia (pooled OR 1.15; 95% CI 1.00-1.32; 23 studies). Meta-analyses of seven RCTs showed increased ferritin, standardized mean difference (SMD) 0.53 (95% 0.21-0.85), but not hemoglobin, SMD 0.36 (95% -0.07 to 0.78), Pv=.1, following anti-H. pylori eradication therapy plus iron therapy as compared with iron therapy alone. Significant heterogeneity was found among studies, as well as evidence of publication bias. CONCLUSIONS: Current evidence indicates increased likelihood of depleted iron stores in relation to H. pylori infection. H. pylori eradication therapy, added to iron therapy, might be beneficial in increasing ferritin and hemoglobin levels.
Authors: Giulia Collatuzzo; Federica Teglia; Claudio Pelucchi; Eva Negri; Charles S Rabkin; Linda M Liao; Rashmi Sinha; Lizbeth López-Carrillo; Nuno Lunet; Samantha Morais; Nuria Aragonés; Victor Moreno; Jesus Vioque; Manoli Garcia de la Hera; Mary H Ward; Reza Malekzadeh; Mohammadreza Pakseresht; Raúl Ulises Hernández-Ramírez; Malaquias López-Cervantes; Rossella Bonzi; Michela Dalmartello; Shoichiro Tsugane; Akihisa Hidaka; M Constanza Camargo; Maria Paula Curado; Zuo-Feng Zhang; Nadia Zubair; Carlo La Vecchia; Shailja Shah; Paolo Boffetta Journal: Nutrients Date: 2022-06-20 Impact factor: 6.706
Authors: Doreen Montag; Carlos A Delgado; Consuelo Quispe; David Wareham; Valentina Gallo; Jose Sanchez-Choy; Víctor Sánchez; Ruth Anaya; Elaine Flores; Lorena Roca; Víctor Mamani; Juan Rivera Medina; Pablo Velasquez; Carlos Del Aguila; Andrew Prendergast; Julio Palomino Journal: BMJ Open Date: 2021-05-13 Impact factor: 2.692
Authors: Martin N Mwangi; Kamija S Phiri; Abdelhak Abkari; Mory Gbané; Raphaelle Bourdet-Sicard; Véronique Azaïs Braesco; Michael B Zimmermann; Andrew M Prentice Journal: Nutrients Date: 2017-06-05 Impact factor: 5.717
Authors: Monika Burns; Aldo Amaya; Caroline Bodi; Zhongming Ge; Vasudevan Bakthavatchalu; Kathleen Ennis; Timothy C Wang; Michael Georgieff; James G Fox Journal: PLoS One Date: 2017-03-29 Impact factor: 3.240